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(McMichael and O'Callaghan, 1998). Here, we use one of
these methods, intracellular cytokine staining (ICS) (Jung
et al., 1993), in conjunction with biochemical analysis and
ER-targeted minigene-expressing recombinant vaccinia
viruses (rVVs) to comprehensively examine the factors
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Bethesda, Maryland 20892-0440 that account for the hierarchy of H-2 Kd-restricted TCD81
responses to influenza virus.
Summary Results
Following influenza virus infection, the numbers of Establishing the Hierarchy: Quantitating Antiviral
mouse TCD81 cells responding to five different determi- TCD81 Responses to Individual Determinants
nants vary more than 50-fold in primary responses but Infection of BALB/c mice with PR8 influenza virus results
less so in secondary responses. Surprisingly, each in the priming of Kd-restricted memory TCD81 (mTCD81) to
determinant elicits a highly diverse and highly sensitive at least five determinants derived from two viral proteins
TCD81 response. Inefficient antigen processing by vi- (nucleoprotein [NP] and hemagglutinin [HA]) that can be
rus-infected cells accounts for the poor immunogenic- detected by TCD81-mediated lysis following 7 day in vitro
ity of just one of the subdominant determinants. Over- stimulation with synthetic peptides (Deng et al., 1997).
expressing class I±peptide complexes using vaccinia To gain a more precise measure of the TCD81 response,
virus revealed that the poor immunogenicity of two we used ICS to quantitate the numbers of splenic TCD81
subdominant determinants reflects limitations in T cell and peritoneal TCD81 that respond to each determinant
responses unrelated to TCR diversity or sensitivity. at four intervals following infection, as determined using
Despite greatly enhanced expression, the immuno- peptide-pulsed antigen-presenting cells (APCs).
dominant determinant is actually less immunogenic Figures 1A and 1B demonstrate that responses of
when overexpressed by vaccinia virus. Immunodomi- both peritoneal and splenic primary TCD81 (pTCD81) reach
nance is also modulated by determinant-specific vari- detectable levels between days 3 and 5 post infection,
ations in the capacity of TCD81 to suppress responses peaking on or about day 7 and declining by day 11. Con-
to other determinants. firming and extending our previous findings, NP147-155-
specific TCD81 were prevalent among both splenic and
peritoneal TCD81. The next most prevalent TCD81 popula-Introduction
tion was HA518-526-specific TCD81, which was the only
other population detected in the spleen in this experi-Immunodominance is a central feature of CD81 T cell
(TCD81) responses to pathogens (Zinkernagel and Doh- ment. Responses to NP39-47 were detected among perito-
neal TCD81, while splenic and peritoneal responses toerty, 1979; Yewdell and Bennink, 1999). Few of the enor-
mous number of peptides encoded by the pathogen NP218-226 and HA462-470 were too close to background val-
ues to be reliable.elicit responses, and, even among the chosen few, re-
sponses are often skewed heavily to one or several pep- We next compared peak pTCD81 responses (day 7
following infection) with mTCD81 responses, using bothtides (termed immunodominant determinants [IDDs]) at
the expense of the others (termed subdominant determi- ICS (panel C) and lytic activity to gauge responses (panel
D). Peptide-specific pTCD81-mediated lysis is exclusivelynants [SDDs]) (Sercarz et al., 1993). A detailed account-
ing of immunodominance is essential to understanding directed to NP147-155, while ICS of the same population
reveals responses to NP147-155 as well as to SDDs HA518-526cellular immunity, viral evasion mechanisms, and the
rational design of vaccines. and NP39-47. The percentage of responding TCD81 in this
experiment is z3-fold higher than that shown in panelIt is not difficult to identify the factors that potentially
contribute to immunodominance. These include the A, which probably accounts for the detection of NP39-47-
specific splenic pTCD81.binding of peptides to class I molecules, the efficiency
of antigen presentation, the presence of T cells capable mTCD81 specific for NP147-155 and HA518-526 were detected
at 2- to 3-fold lower frequencies than pTCD81 (panelof responding to a given complex, and immunodomina-
tion: the suppression of responses to SDDs by IDD- C). Surprisingly, the less vigorous primary responses to
NP39-47 demonstrated a smaller decrease among mTCD81.specific TCD81. The trick lies in weighing the relative
contributions of each of these factors to immunodomi- Responses to NP218-226 and HA462-470 remained near the
limits of detection by ICS. Following 7 day stimulationnance, as TCD81 responses ultimately reflect the mathe-
matical product of the individual factors. of mTCD81 with PR8 infected-P815 cells, however, lytic
activity to all of the determinants could be detectedStudies of TCD81 have been greatly aided by the intro-
duction of new methods that allow for the accurate quanti- (panel E). In additional experiments performed under
similar conditions, ICS revealed mTCD81 specific for eachtation of TCD81 responding to individual determinants
of the determinants in day 7 in vitro cultures at frequen-
cies consistent with the lytic activities (data not shown).* To whom correspondence should be addressed (e-mail: jbennink@
nih.gov [J. R. B.], jyewdell@nih.gov [J. W. Y.]). These data clearly illustrate, first, that lysis is a partial
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measure of pTCD81 responses and, second, that the
numbers of TCD81 responding to individual determinants
varies widely between determinants, establishing the
immunodominance hierarchy in this system. Although
the absolute numbers of responding TCD81 vary among
individuals and experiments (within a 4-fold range over a
large series of experiments), the ranking of determinants
within the hierarchy was constant in a large number of
animals examined in a number of different experiments.
In what follows, we examine the contribution of the indi-
vidual factors that contribute to immunodominance.
Peptide Affinity for Kd
We improved our previous examination of peptide bind-
ing to Kd (Deng et al., 1997) in two important ways. First,
we analyzed the binding of Cys containing peptides
(NP218-226, NP39-47) in the presence of a reducing agent,
since sulfhydryl modification of the Cys residue on these
peptides affects their binding to Kd (Chen et al., 1999).
Second, we compared peptide off rates from cell surface
Kd molecules, since this has been reported to correlate
better with immunogenicity than the overall dissociation
constant (van der Burg et al., 1996).
Peptide affinity and dissociation were measured using
Kd-transfected T2 cells (a TAP-deficient human lymphoid-
derived cell line) that were incubated overnight at 268C
to enhance expression of peptide-receptive cell surface
molecules. Peptide affinity was estimated by adding
decreasing amounts of peptides to cells and then shift-
ing cells to 378C for 2 hr to unfold Kd molecules lacking
a peptide ligand. The expression of conformed cell sur-
face Kd was determined by flow cytometry using a con-
formationally sensitive mAb conjugated to fluorescein.
The concentration of peptide required for rescue of 50%
of the Kd molecules provides an estimate of the dissocia-
tion constant (KD) of the peptide±Kd interaction.Figure 1. Hierarchy of Kd-Restricted Responses to PR8 Infection of
BALB/c Mice As shown in Figure 1F, all five peptides stabilized
surface Kd molecules in a dose-dependent manner. Rel-BALB/c mice were infected with PR8 by intraperitoneal injection,
and 3, 5, 7, and 11 days later, splenic (A) and peritoneal (B) TCD81 from ative to NP147-155, NP39-47, HA518-526, and HA462-470 displayed
four individuals were analyzed by ICS after activation by peptide- higher affinity binding to Kd while NP218-226 exhibited z10-
sensitized APCs. Error bars correspond to the standard deviation of fold lower affinity (KD estimates given in Table 1). Thesethe values. Background values obtained with nonpeptide-stimulated
differences are reflected in the off rates, determined bycells were subtracted from each individual. In a separate experi-
pulsing cells with a saturating concentration of peptide,ment, splenic TCD81 obtained 7 days post infection were analyzed
washing, and then incubating for increasing times atby ICS ([C], ªprimaryº) or tested directly ex vivo for lysis against
peptide-sensitized 51Cr-labeled cells at the indicated effector to target 378C (Figure 1G).
cell ratio (E:T) (D). Additionally, 21 days after priming, splenic TCD81 The relevance of these findings to the association of
were either directly used for cytokine staining ([C], ªmemoryº) or stimu- naturally processed peptides with Kd molecules in the
lated by PR8-infected P815 cells for 7 days and tested for lysis against
ER is fully supported by the next experiment. Recombi-peptide-sensitized 51Cr-labeled P815 cells (E). In (C), background val-
nant vaccinia viruses expressing ER-targeted forms ofues of .71% and .22% obtained by activating with nonpeptide-sensi-
the peptides (Deng et al., 1997) were tested for theirtized cells were subtracted, respectively, from values for pTCD81
and mTCD81 responses. In F, T2-Kd cells cultured at 268C were incu- abilities to enhance the expression of Kd molecules on
bated with peptides at the indicated concentrations for 1 hr, and surface of T2-Kd cells infected at 378C (Figure 1H). The
Kd molecules remaining after incubation at 378C for 2 hr determined degree of rescue of Kd molecules matched the rank
by direct immunofluorescence and flow cytometry. Data are expressed
order of peptide affinity for Kd determined using syn-as mean channel fluorescence (MCF). Similarly (G), T2-Kd cells incu-
thetic peptides, with a single exception (HA518-526 beingbated with a saturating concentration of peptide were washed and
slightly better than NP39-47; this may be related to a de-incubated at 378C in the presence of BFA for the indicated time prior
to direct staining. Data are expressed as the percentage of the creased affinity of the mAb used for detection for com-
initial MCF obtained with each peptide. Finally (H), T2-Kd cells were plexes of Kd and NP39-47 with human b2m). These findings
infected for 6 hr at 378C with either a control rVV or rVVs coding indicate that peptide association in the ER is similar to
various ER-targeted determinants. Cells were stained as above for
the binding of synthetic peptides to cell surface mole-Kd cell surface expression and analyzed by flow cytometry. Solid
cules and confirm that targeting peptides to the ERlines represent staining of cells infected with the control virus. Stain-
usually results in the generation of tens of thousandsing an mAb specific for an early VV encoded protein indicated that cells
were infected to a similar extent by the VV vector (data not shown). of class I±peptide complexes (AntoÂ n et al., 1997).
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Table 1. Immunodominance by the Numbers
A B C 5 (A3B) D E 5 (D/C)
Name Sequence KA (3 107 M21) KL (3 10212 M) Threshold Determinants Per Cell Predicted Speed
NP39±47 FYIQMCTEL 2.88 5.8 16.7 Low Glacial
NP147±155 TYQRTRALV 0.79 1.2 .94 808 860
NP218±226 AYERMCNIL 0.22 5.8 1.27 z300 236
HA462±470 LYEKVKSQL 1.68 3.6 6.05 4870 805
HA518±526 IYSTVASSL 1.05 1.2 1.26 1616 1283
Column A shows the KA derived from the peptide concentration calculated to rescue one-half of Kd molecules from the data in Figure 1F.
Column B shows the peptide concentration required to achieve half maximal lysis of target cells in Figure 3. Column C is the product of
columns A and B and provides a relative (but linear) comparison of the number of complexes per cell required for target cell lysis. Column D
shows the number of peptides isolated per cell as estimated using the data in Figure 2. Column E results from dividing column D by column
C and provides a prediction of the kinetics of sensitization for TCD81 lysis confirmed in Figure 2.
Antigen Processing measurements of peptide affinity and complex forma-
We next quantitated the numbers of peptide±Kd com- tion. Importantly, they also demonstrate functionally
plexes produced by PR8-infected cells as previously that the production of NP39-47, and to a lesser extent
described by Rammensee and colleagues (Falk et al., NP218-226, are limiting relative to the other determinants
1991) by HPLC purification of peptides present in acid in the context of the sensitivity of their cognate TCD81.
extracts. With the exception of NP39-47, we were able to
detect each of the determinants in fractions that co- pTCD81 Response: Diversity
eluted with the corresponding synthetic peptides (Figure We examined the diversity of pTCD81 responding to each
2). For HA462-470 and HA518-526, this provides the initial evi- of the determinants using mAbs specific for the various
dence that the naturally processed peptide is identical Vb gene products using micromagnetic beads coated
to the synthetic nonameric peptide that matches the Kd with anti-fluorescein antibodies to bind TCD81 labeled
binding motif. We determined the efficiency of recovery with fluorescein-conjugated anti-Vb mAbs. Positively
of each of the peptides from cells (ranging from 10%± and negatively selected TCD81 were characterized for
12%) by measuring the amount of peptide recovered in Vb expression by flow cytometry and for lytic activity
HPLC fractions from uninfected cells to which peptides against peptide-sensitized target cells.
were added during homogenization. Using this figure, Using TCD81 derived from PR8-infected mice and re-
along with the concentration of peptide calculated to stimulated in vitro with PR8-infected cells, most lytic
be present in the fraction by comparison to a synthetic activity (z 2/3) against peptide sensitized-cells is medi-
peptide standard curve, we could calculate the number ated by Vb8.1/21 TCD81 (Figures 3A and 3B). The lyticof peptides recovered per cell (Table 1D). activity of Vb8.1/21 TCD81 is predominantly directedThere are a number of limitations to quantitating pep- against NP147-155, but this population also contains TCD81tides by this method, including an inability to distinguish
specific for each of the four SDDs. NP147-155-specificintracellular from cell surface complexes and a reliance
TCD81 still dominate the Vb8.1/2 depleted cells (Figureon assumptions regarding peptide recovery efficiency
3B). This cannot be attributed to contamination byand the identity of synthetic and naturally processed
Vb8.1/21 cells, which are reduced to 0.03% or less ofpeptides. We therefore sought an independent means
the population as determined cytofluorographicallyof testing the validity of the peptide quantitation. By
(data not shown). TCD81 specific for three of the fourmultiplying the estimated peptide affinities for Kd by the
SDDs (all but HA462-470) are detected in this populationpeptide concentration required for target cell sensitiza-
at somewhat higher levels relative to NP147-155-specifiction, it is possible to rank the relative number of com-
TCD81. Removal of Vb61 and Vb8.31 TCD81 from theplexes needed for TCD81 detection (Table 1, ªthresholdº).
Vb8.1/22 cells (which account for 20% of the cells) selec-Dividing the number of determinants present in infected
tively removed about half of the NP218-226 activity and hadcells by this threshold value results in prediction of the
little effect on other specificities (Figure 3C). Removalvelocity of presentation following infection. This predic-
of Vb101 cells from the Vb8.1/22 Vb62 population dimin-tion should be valid for different determinants presented
ished HA462-470 reactivity to undetectable levels, with littlefrom the same viral protein, and even between proteins,
effect on the other populations (Figure 3D).if the two proteins are expressed with similar kinetics.
We confirmed and extended this analysis by Vb stain-The kinetics of complex formation were determined
ing of determinant-specific TCD81 identified by ICS fol-experimentally by adding BFA to cells at increasing in-
lowing stimulation with PR8-infected P815 cells (Figuretervals after PR8 infection to block export of nascent
3E). Most NP147-155-specific TCD81 expressed Vb8.1/2,class I±peptide complexes from the ER (AntoÂ n et al.,
with a substantial number expressing either Vb6, Vb7,1997). As seen in Figure 2, HA462-470 reaches saturating
or Vb14, and some responding clones expressing Vb2,concentrations first, followed by NP147-155, HA518-526, and
Vb4, Vb8.3, Vb9, Vb10, Vb11/12 (mAbs specific for eachNP218-226. NP39-47 never reached saturating levels in this
were mixed), or Vb13. Remarkably, TCD81 respondingassay. With the minor exception of the slight tardiness
to each of the SDDs were similarly diverse in their Vbof HA518-526 (which is probably accounted for by a de-
expression.crease in the sensitivity of the HA518-526-specific TCD81
Based on this analysis, we conclude that the responseused in this assay), these findings agree with the pre-
dicted kinetics, thereby supporting the validity of our to each of the five determinants is multiclonal. Through
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Figure 2. Quantitation of Peptide±Kd Complexes
Peptides were acid extracted from PR8-infected P815 cells and fractionated by HPLC, and the individual fractions were tested for their ability
to sensitize cells for lysis by short-term TCD81 lines specific for the determinant indicated (left panel). Arrows point to the peak fractions in
which corresponding synthetic peptides elute under identical conditions. TCD81 lines were also assayed for their dose response toward their
cognate peptides (second panel from the left) and in the same assay against dilutions of fractions containing antigenic activity (third panel
from the left; only the peak fraction is shown, but minor fractions were also titrated and used for the calculation in Table 1). Using data from
the second and third panels in conjunction with the efficiencies of peptide recovery calculated by spiking peptides at 0.1 nM into uninfected
cell lysates (ranging between 10%±12%), we calculated the number of peptides recovered per cell (Table 1). The first panel on the right shows
the kinetics of presentation of the various determinants to short-term TCD81 lines that were serially diluted in the 96-well plates before the
addition of 51Cr-labeled P815 cells infected for 2 hr with PR8. BFA was added at a concentration of 10 mg/ml at this time (ª2 hº) and then for
each of the next 5 hr. Supernatants were harvested 1 hr after the last BFA time point (ª7 hº). On the assay day, TCD81 lines had similar dose
response toward the respected peptide as shown in the middle panel (data not shown), with the exception of TCD81 specific for HA518-526, which
required z3-fold more peptide to achieve similar levels of lysis as shown here. In other similar assays, HA518-526 and NP147-155 were presented
with similarly rapid kinetics (data not shown).
repeated stimulation, it was possible to generate NP147-155- surface complexes. Using this panel of rVVs expressing
ER-targeted peptides, we could compare immunogenic-specific TCD81 lines that express the following Vb chains;
8.1/2, 8.3, 6, 10, 7, and 9 (data not shown). Importantly, ity under conditions in which class I peptide complexes
far exceed levels of naturally presented peptides (Figurethe lines demonstrated nearly indistinguishable peptide
dose responses (data not shown). This indicates that 4A). Each rVV elicited similarly vigorous VV-specific re-
sponse 7 days following immunization with 11%±13%numerous widely different TCRs are capable of recog-
nizing a single viral peptide with similarly high sensitivity. of TCD81 activated by VV-infected cells as determined
by ICS (ES-NP147-155 elicited a lower response in the ex-
periment shown, but this was not consistently observedpTCD81 and mTCD81 Responses: Effects of Increasing
Complex Numbers on APCs between experiments). Despite the overexpression of
the influenza peptides, the response to even the IDD,The cytofluorographic detection Kd molecules following
infection of T2-Kd cells with rVVs expressing ER-targeted NP147-155, which constituted 1.6% of TCD81 cells, consti-
tuted only 12% of the VV-specific response (Figure 4A).peptides corresponds to tens of thousands of cell
Mechanisms of Immunodominance
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Figure 3. Diversity of TCD81 Responses
Splenocytes from PR8 primed animals were
restimulated in vitro for 7 days with PR8-
infected P815 cells and IL-2, and live cells
recovered from Ficoll-Hypaque (.95% CD81
as determined by flow cytometry) were posi-
tively selected for expression of Vb8.1/8.2 (A)
or depleted sequentially of cells expressing
Vb8.1/8.2 (B) Vb6 (C) and Vb8.3/Vb10 (D). Se-
lected populations were tested for their abili-
ties to lyse peptide-sensitized 51Cr-labeled
P815 cells at the indicated E:T ratio. In (E),
similarly in vitro±stimulated splenocytes were
activated by specific peptide-pulsed P815,
and CD81 IFNg-expressing cells identified by
ICS were further stained with the indicated
Vb-specific mAb.
Since VV infection results in a z2-fold increase in the Effect of Preexisting mTCD81 on the
Immunodominance Hierarchynumber of TCD81, as compared with a z1.3-fold increase
following PR8 infection, to compare absolute numbers of The response of mTCD81 in vivo was examined by immu-
nizing mice with VV-ES-X, challenging 40 days later withresponding cells, the percent of responding cells following
VV infection must be multiplied by 1.5. Thus, in absolute PR8, and measuring TCD81 activation ex vivo 7 days later
using peptide-sensitized APCs (Figure 5B). This resultednumbers, the response to NP147-155 induced by ES-NP147-155
was z2-fold less than that induced by PR8. in the expansion of each of the primed mTCD81 popula-
tions specific for the corresponding determinant. Prim-Using the response to NP147-155 as a means of normaliz-
ing PR8 and VV-ES-X-induced responses, responses to ing with ES-NP147-155 had only a marginal enhancing effect
on the numbers of NP147-155-responding TCD81 relative toES-NP39-47 and NP218-226 demonstrate, respectively, 10-
and 3-fold enhancements, while the response to HA518-526 unprimed mice. These cells were clearly different func-
tionally from pTCD81, however, since they blocked theis unchanged (Figure 4A). Most impressively, the re-
sponse to HA462-470 remains undetectable. When the PR8-induced expansion of primary TCD81 to each of the
other determinants. Such mTCD81-mediated suppres-same TCD81 were tested for lysis of peptide-sensitized
target cells, there was a close correlation between lytic sion is a well-known feature of immunodomination (Ben-
nink and Doherty, 1981; Jamieson and Ahmed, 1989).activity and the number of cytokine-secreting cells (Fig-
ure 4B). mTCD81 specific for the other determinants demon-
strated an intermediate phenotype and their capacityThe abilities of rVVs encoding ER-targeted peptides
to prime for mTCD81 responses 6 weeks following immu- to block responses to unprimed determinants varied
considerably and in an interesting manner.nization were similarly examined (Figure 5A). The num-
ber of NP147-155-specific mTCD81 was z50% of the value mTCD81 specific for HA518-526, HA462-470, or NP218-226
blocked responses to unprimed SDDs and partially in-following PR8 infection. As with the pTCD81, NP39-47-spe-
cific mTCD81 demonstrated the greatest increase relative hibited responses to NP147-155. The degree of inhibition of
NP147-155 TCD81 was proportional to the number of mTCD81to the PR8-induced response (6-fold), even surpassing
the number of NP147-155 mTCD81. In the same terms, the responding to the priming determinant. Despite their abun-
dance, NP39-47-specific mTCD81 only blocked NP147-155-relative proportion of HA462-470 mTCD81 increased 3-fold,
while the HA518-526 mTCD81 response is unaffected and specific response to a similar extent as HA518-526-specific
TCD81. Moreover, they did not block the primary re-NP218-226 may even decrease, as it is now below the limit
of detectability. sponse to HA518-526, while conversely HA518-526 mTCD81
blocked the response to NP39-47. Indeed, pTCD81 re-These findings indicate that overexpression of sub-
dominant determinants can increase their immunoge- sponding to any of the determinants was able to pro-
foundly block NP39-47-specific TCD81. The lytic activitynicity but that the effect varies considerably with the
determinant and between pTCD81 versus mTCD81. of mTCD81 on target cells sensitized with the different
Immunity
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Figure 4. Quantitation of pTCD81 Responses
to VV-ES-X Infection
(A) BALB/c mice were infected by rVVs ex-
pressing the ER-targeted peptide indicated,
and 7 days later splenocytes were prepared
and the number of cells responding to P815
cells sensitized with the peptide indicated
was enumerated by ICS. Corresponding
background values ranging from 0.75% to
1.45% obtained by stimulating with cells not
exposed to peptide were subtracted from
each data point. An rVV (ªES-HA204º) express-
ing a Kd binding peptide from a unrelated in-
fluenza virus was included as a control.
(B) A sample of the splenocytes used in (A)
were assayed for lytic activity against either
virus-infected or peptide-pulsed 51Cr-labeled
P815 cells at the E:T ratio indicated.
peptides closely reflected the numbers of cells deter- following vaccination with the various VV-ESX viruses,
NP147-155-specific TCD81 completely inhibited responsesmined by ICS (Figure 5C). These findings demonstrate
that mTCD81 to different determinants can exhibit major to all of the SDDs, and each of the SDD-specific TCD81
lines partially inhibited the primary response to NP147-155.qualitative differences in their ability to exert immuno-
domination. Accounting for pTCD81 responses, NP39-47-specific TCD81
again demonstrated both the greatest specific expan-
sion and the least effect on NP147-155-specific pTCD81 re-Effect of Passively Transferred TCD81
sponses. This is similar to the properties of mTCD81on the Immunodominance Hierarchy
induced by VV-ESNP39-47. HA518-526-specific TCD81 demon-We next examined the relationship between the ID sta-
strated the smallest specific expansion but still managedtus of determinants and the abilities of their correspond-
to exert the greatest suppressive effect on NP147-155-ing mTCD81 to persist in vivo and exert immunodomina-
specific responses. Curiously, HA462-470-specific TCD81tion. To level the playing field, we passively transferred
exerted greater relative inhibition on HA518-526-specificequal numbers (2 3 106 cells) of mTCD81 that had been
TCD81 than on TCD81 specific for the other determinants.generated by multiple rounds of in vitro stimulation with
This selective inhibition was observed in several addi-individual peptides. TCD81 lines specific for each peptide
tional experiments, but not completely consistently.demonstrated similar peptide dose responses (data not
The lytic activity of TCD81 on target cells sensitized withshown). ICS revealed that .95% of the cells present in
the different peptides closely reflected the numbers ofthese cultures were specific for their cognate determi-
cells determined by ICS, with the exception of NP218-226-nants (data not shown). Two weeks after the final restim-
specific TCD81, which demonstrated lower activity thanulation, cells were transferred into naive BALB/c mice,
predicted.either separately or all five lines together.
We further explored asymmetries in immunodomina-Ten to twelve weeks later, the survival of functional
tion by transferring a greater number of mTCD81 (7 3 106transferred TCD81 in mice was measured by ICS (Figure
cells) prior to PR8 infection and ex vivo ICS on day 76A). This ranged from 0.02% to 0.1% of the total number
post infection (panel D). As expected, NP147-155-specificof TCD81 recovered from spleens. The recovery of SDD-
TCD81 still completely suppressed responses to thespecific TCD81 was similar or better than the recovery of
subdominant determinants. Increasing the number ofNP147-155-specific TCD81 following individual transfer. In-
HA518-526-specific TCD81 resulted in complete suppressiondeed, following multiple transfer, the recovery of NP147-155-
of NP39-47-specific TCD81 and reduced yet did not com-specific TCD81 was the least efficient of the five lines.
pletely suppress NP147-155-specific TCD81.The function of transferred TCD81 in vivo was examined
These experiments indicate that TCD81 specific forby measuring ICS (Figure 6B) and lysis (Figure 6C) ex
vivo 7 days after challenging mice with PR8. As observed IDDs and SDDs can have a similar capacity to persist
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Figure 5. Quantitation of mTCD81 Responses to VV-ES-X Infection
(A) BALB/c mice infected for 6 weeks previously with the indicated rVV and splenic mTCD81 were quantitated by ICS. Corresponding background
values ranging from 0.27% to 0.45% obtained by stimulating with cells not exposed to peptide were subtracted from each data point.
(B) BALB/c mice infected with the indicated rVV 35 days previously were infected with PR8, and 7 days later specific splenic TCD81 were
quantitated by ICS. Corresponding background values ranging from 0.39% to 0.52% obtained by stimulating with cells not exposed to peptide
were subtracted from each data point.
(C) A sample of the splenocytes used in (B) were assayed for lytic activity against either virus-infected or peptide-pulsed 51Cr-labeled P815
cells at the E:T ratio indicated.
in a functional state in vivo and also reinforce the conclu- products (Vb2, 4, 8.1/8.2, 9, 11, or 12). Further, the TCD81
that are elicited are not silenced or deleted more rapidlysion that the capacity for immunodomination varies con-
siderably with the specificity of TCD81, suggesting that than TCD81 to other SDDs or the IDD, as indicted by
transfer experiments and the persistence of mTCD81.domination is a cause rather than an effect of the immu-
nodominance hierarchy. This points to either a very low absolute number of
precursors and/or some mechanism that limits expan-
sion of the precursors. Low numbers of precursors couldDiscussion
result from an intrinsic difficulty in producing high-affin-
ity TCRs given the genes available for the task or difficul-Hierarchy Rules
Our analysis of immunodominance in the Kd-restricted ties in producing such TCRs that do not cross-react
with self-antigens with too high an affinity.response to PR8 in BALB/c mice demonstrates, first,
that determinants are recognized in a hierarchy that is d-determinant NP218-226 has the lowest affinity for Kd,
stemming at least in part from possessing the highesthighly stable between individual animals and, second,
that the hierarchy is based on multiple factors. We adopt off rate. The low affinity correlates with its poor rescue
of Kd molecules when targeted to the ER of T2-Kd cellsthe nomenclature used to describe animal hierarchies
and refer to the position of determinants using Greek (correcting a lamentable error in our original publication
describing VV-ES-NP218-226 [Deng et al., 1997]). Assumingcharacters a, b, etc., based on the prevalence of re-
sponding TCD81 cells. that TAP-transported peptides exhibit a similarly low
affinity, this is probably the major factor in the relativelye-determinant HA462-470 makes a bold statement, as it
is the determinant most abundantly expressed by PR8- low number of complexes produced by infected APCs.
pTCD81 responses were not enhanced by immunizationinfected cells yet is the least immunogenic following PR8
infection. In conjunction with the failure of ES-HA462-470 with VV-ES-NP218-226 (although mTCD81 were effectively
elicited). Although ES-NP218-226 only marginally increasesto enhance immunogenicity despite producing even
greater numbers of complexes on infected APCs, this Kd expression in T2-Kd cells, it is presented much more
rapidly than full-length NP expressed either by VV oremphatically points to deficiencies in responding TCD81
as the cause of low immunogenicity. This is not due, PR8 (Deng et al., 1997), which indicates that ER targeting
does enhance the generation of complexes. This sug-however, to an absolute inability of TCD81 to recognize
HA462-470±Kd complexes, since highly sensitive TCD81 gests that the limitations in responding TCD81 are a major
factor in the poor primary response to NP218-226. It isclearly exist and can utilize at least five different Vb gene
Immunity
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Figure 6. Functional Properties of Passively Transferred Short-Term TCD81 Lines
(A) Naive BALB/c mice received by i.v. injection either 2 3 106 cells of a single TCD81 line specific for the peptide indicated (right panel) or a
mixture of all 5 TCD81 (2 3 106 of each line). 10±12 weeks later, the number of responding splenic TCD81 was determined by ICS. Corresponding
background values ranging from 0.23% to 0.33% obtained by stimulating with cells not exposed to peptide were subtracted from each data
point.
(B) BALB/c mice receiving TCD81 specific for the indicated determinant 10±12 weeks previously were infected with PR8, and 7 days later the
number of responding splenic TCD81 was determined by ICS. Corresponding background values ranging from 0.56% to 1.07% obtained by
stimulating with cells not exposed to peptide were subtracted from each data point.
(C) A sample of the splenocytes used in (B) were assayed for lytic activity against either virus infected or peptide pulsed 51Cr-labeled P815
cells at the E:T ratio indicated.
(D) As in (B), but mice received 7 3 106 of NP147-155- or HA518-526-specific TCD81.
also possible, however, that the primary factor is the b-determinant HA518-526 is clearly dominated by NP147-155.
This cannot be attributed to inefficient antigen pro-relatively high off rate of the peptide.
Another complicating factor in the poor immunogenic- cessing by virus-infected cells (assuming that APCs in
vivo process antigens similarly to P815 cells) nor toity of NP218-226 is the presence of a Cys residue: to reduce
the complexity and increase the reproducibility of the gross deficiencies in the TCD81 repertoire elicited by
the determinant, which is highly diverse. In contrast toassays, we included reducing agents whenever using
Cys containing peptides. We previously demonstrated NP39-47, overexpression using VV-ESHA518-526 did not im-
prove the response, suggesting an intrinsic limit in thethat TCD81 specific for cysteinylated NP218-226 are elicited
by PR8 infection (Chen et al., 1999), and the contribution capacity of HA518-526-specific TCD81 to expand. This may
be a less extreme example of the mechanism that limitsof these TCD81 to anti-PR8 responses remains to be
established, as does their possible immunodominating responses to HA462-470.
a-determinant NP147-155 also makes a strong statement,effects on TCD81 specific for unmodified NP218-226.
g-determinant NP39-47 beautifully illustrates the contri- as it demonstrates that an a determinant need not be
the most abundant nor exhibit the slowest off rate. Givenbution that antigen processing can play in immunodomi-
nance: it has the highest affinity for Kd and is perfectly its relatively low affinity for Kd, its processing and deliv-
ery to the ER may be somewhat better than the averagecapable of eliciting a vigorous TCD81 response when
expressed at sufficiently high levels. Indeed, in the con- class I ligand, since a reasonable number of complexes
are created by PR8-infected cells (800 per cell). Thetext of the ER-targeted determinants, ESNP39-47 moves
to the top of the immunodominance hierarchy. Its status efficiency of producing the determinant does not appear
to limit its immunogenicity in the context of PR8, sinceas the g-determinant in the context of PR8 infection
clearly reflects a deficiency in antigen processing. Given VV-ES-NPNP147-155 elicits less NP147-155-specific TCD81 than
does PR8 (on the other hand, as discussed below, thereits very low levels of expression on infected cells, the
magnitude and diversity of the response induced by are limitations in comparing between the immunogenici-
ties of different viral vectors). The secret to NP147-1559s aPR8 infection indicates that TCD81 eagerly await its ap-
pearance. status clearly lies in the capacity of TCD81 to respond to
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the peptide. This is not a ªjackpotº phenomenon, in Second, NP147-155-specific mTCD81 were both most ef-
fective at immunodomination and most capable of re-which a single abundant TCD81 clone or highly related
family of clones recognize the determinant (Bousso et sisting the domination by other mTCD81. This phenome-
non probably lies at the heart of the immunodominanceal., 1999). Clearly, TCD81 of high sensitivity bearing differ-
ent Vb chains are present in the responding population. of NP147-155 in primary responses. The ability of NP147-155
to withstand the suppressive effects of preexisting TCD81Others have observed that responses to a-determinants
can be highly diverse, and it has been shown in both to other determinants strongly suggests that the immu-
nodominance of NP147-155 is not simply due to a greaterhuman and mouse systems that upon elimination of a
dominant TCD81 clonotype, others can take their place number of responding cells that stochastically result in
more rapid response. One explanation is that NP147-155±Kd(this forms a parallel hierarchy in the TCD81 response)
(Burrows et al., 1995; Jones et al., 1997; Wallace et al., complexes have an inherent ability to optimally trigger
cognate TCRsÐinherent in deference to the observation1999). Responses to a-determinants represent the other
side of the looking glass relative to the SDD-specific that the response to NP147-155 is highly diverse. Alterna-
tively, the presentation of NP147-155 in vivo may be far moreTCD81, requiring the opposite sorts of explanations, i.e.,
high number of NP147-155-specific precursors, increased efficient than its presentation in vitro, e.g., NP147-155 may
be selectively presented at high efficiency by cross-proliferative capacity, and enhanced ability to exert im-
munodomination. priming.
Third, transferred HA462-470 TCD81 more effectively
blocked responses to HA518-526 than to NP determinantsConclusions following PR8 infection. Admittedly, the sample size is
These findings illustrate how numerous factors can minimal (and the effect was not observed in every experi-
combine to establish an immunodominance hierarchy. ment), but this finding suggests that under some circum-
Deeper insight into immunodominance hinges on better stances immunodomination can be protein specific.
understanding the properties of responding TCD81, with Since it is difficult to imagine how this could happen if
an emphasis on discerning the number of precursors in afferent APCs are presenting endogenously synthesized
naive animals, the relationship between TCD81 sensitivity antigens, this finding points to a cross-priming mecha-
and TCR avidity for cognate class I±peptide complexes, nism in which APCs present HA but not NP. The capacity
and the differences among TCD81 clones in their prolifer- of HA as a sialic acid receptor lends some plausibility
ative capacities, antiviral activities, and suppressive ef- to this scenario, since it may enable HA to be selectively
fects on other responding TCD81 (discussed further acquired by cross-priming APCs.
below).
Implications for Vaccines
Our findings indicate that following a single i.p. immuni-Mechanistic Issues
Cytokine/Lysis Disconnect zation with influenza virus there is less bias among
Kd-restricted TCD81 toward the IDD among mTCD81 thanIn several situations, we noted discrepancies between
the lytic activity of TCD81 specific for a given determinant pTCD81. Similarly, studying responses to a Sendai virus
determinant that is presented by both Kb and Db, Coleand the number of activated cells identified by ICS. This
is consistent with the idea that activated TCD81 can vary et al. (1997) found that pTCD81 populations are more
skewed toward Kb-restricted TCD81 than mTCD81 popula-in their lytic potential and that this occurs in a determi-
nant-specific manner. This raises a number of questions tions. By contrast, Busch et al. (1998) found that for
Kd-restricted Listeria monocytogenes, the ratios offor future investigation, including the cause for the de-
creased lytic activity, how this is regulated on a determi- pTCD81 and mTCD81 among three determinants were sim-
ilar. The extent to which this discrepancy relates to dif-nant level, and the advantages conferred to TCD81 by
independent regulation of lysis and cytokine release. ferences in the antigens versus the responding TCD81
remains to be determined. Moreover, a critical issueSelective Immunodomination
Immunodomination, which is a feature of both primary for vaccines is the ability of mTCD81 induced by prior
immunization to function following infection with theand memory TCD81 responses, is poorly understood at
the mechanistic level. In the present study, we provide natural pathogen. Flynn et al. (1998) have examined this
issue in their studies of H-2b-restricted responses toseveral clues to the puzzle of immunodomination.
First, despite a vigorous response, mTCD81 specific influenza virus. In this system, the IDD is NP366-374 (Db
restricted), and the major SDD is NS114-121 (Kb restricted).for NP39-47 (particularly those elicited by immunization
with VV-ES-NP39-47) exhibited low immunodomination of Prior i.p. immunization resulted in up to a 10-fold en-
hanced response to the IDD in cells recovered from thethe other determinants. By contrast, lower numbers of
mTCD81 to any of the other determinants completely lungs, while the response to the SDD was only slightly
enhanced or even reduced. Importantly, the frequencysuppressed NP39-47-specific responses. It seems likely that
this is related to the inefficient generation of NP39-47 and of mTCD81 in the spleen was not an accurate predictor of
local TCD81 responses; 4- to 6-fold difference in splenicis consistent with poor presentation by afferent and ef-
ferent APCs resulting in delayed clearance of virus and mTCD81 parlayed in up to a 100-fold difference in TCD81
recovered from actively infected lungs.decreased interference with presentation to pTCD81, ei-
ther of which could interfere with immunodomination. These latter findings do not necessarily reflect poorly
on the vaccine potential of SDDs. The primary reasonsThe former has been suggested to account for immuno-
domination in responses of H-2d mice to lymphocytic for including SDDs in vaccines are to increase the num-
ber of responding TCD81 and to prevent the emergencechoriomeningitis virus (LCMV) (Weidt et al., 1998).
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confirmed by flow cytometry using the entire panel of TCR b chain±of viral escape mutants that fail to express IDDs. The
specific mAbs for characterization.enhanced response to the IDD upon local challenge may
be a manifestation of immunodomination in activating
Viruses
mTCD81. Under most circumstances, there is probably rVVs and influenza virus used in this study were produced, propa-
no disadvantage in having the response dominated by gated, and used to infect cells as described previously (Deng et al.,
1997).IDD-specific cells (and this may actually be advanta-
geous in minimizing the chance for autoimmunity [Deng
TCD81 Activationet al., 1997]). Even a minimal response to SDDs may
For in vivo priming, 8- to 10-week-old female BALB/c mice were
mitigate against the emergence of escape mutants, and either injected i.p. with z600 hemagglutinating units of PR8 or in-
in the event of infection with an escape mutant, the jected i.v. with 107 PFU of VV. Splenocytes or cells collected from
presence of SDD-specific mTCD81 will be highly bene- the peritoneal cavity by PBS-lavage were directly assessed after 3
to 11 days for ICS/lytic activity. Alternatively, at least 3 weeks afterficial.
priming, splenocytes were cultured for 7 days in vitro with PR8-We previously reported that primary responses to
infected or peptide-pulsed P815 cells and then assessed for ICS/NP147-155 following infection of mice with a rVV encoding lytic activity. TCD81 were cultured in RP-10 supplemented with 10
NP are difficult to detect (Restifo et al., 1995). This con- U/ml recombinant human interleukin 2 (IL-2). In brief, 3 3 107 spleno-
trasts markedly with the primary response to PR8. More- cytes were stimulated with 6 3 106 to irradiated (220 Gy) P815 cells
infected with PR8 or pulsed with peptides. Viable cultured TCD81over, we show here that even the massive overexpres-
were selected by centrifugation through Ficoll-Hypaque and, insion of NP147-155±Kd complexes resulting from targeting
some cases, enriched by depleting B2201 and CD41 cells usingthe peptide to the ER fails to match the immune re-
M-450 Dynal beads coated with appropriate antibodies.
sponse to PR8. This cannot be attributed to the poor
overall immunogenicity of VV, which, in fact, elicits a Generation of TCD81 Lines
After initial 7 day culture, splenocytes were restimulated weekly inmuch more vigorous TCD81 response than PR8. The most
6-well plates (Becton Dickinson) in the presence of 10 U/ml rIL-2 atlikely explanation for the relatively poor immunogenicity
5 3 106 responders per well and 1/10z1/20 the number of irradiatedof NP147-155 in the context of VV is competition for TCD81 P815 stimulator cells. The purity of each TCD81 population used forresponses between VV determinants and NP147-155. These transfer experiments was determined by ICS upon activation. After
findings point to a limitation in the usefulness of recom- reaching .95% purity, TCD81 were restimulated once and then
ªrestedº for 2 weeks before being transferred into mice. Such restingbinant viral vectors that elicit massive TCD81 response
TCD81 were small and proliferated very slowly.to their own antigens.
A further detriment to using VV or similar vectors is that
Peptides, Binding Assays, and Flow Cytometry
massive responses to VV gene products leave ªscarsº in Peptide binding assays were modified slightly from a previous de-
the TCD81 memory: they result in the generation of large scription (Chen et al., 1999). To examine peptide dissociation, T2-Kd
numbers of long-lived mTCD81 (Sourdive et al., 1998). To cells were incubated at 268C for 12 hr and then pulsed with 10 mM
peptides for 60 min at 268C. BFA (5 mg/ml) was added to cells duringthe extent that the antigen may reappear, this is no
peptide pulsing to prevent the appearance of newly synthesizeddoubt a wise evolutionary strategy, and in the particular
class I molecules. Cells were then washed, aliquoted in BFA-con-case of VV, also probably a wise public health strategy taining medium, and transferred to 378C. Starting at this time point,
given the recent fears regarding the introduction of vari- cells were harvested onto ice, and, following the final time point,
ola virus into human populations. On the other hand, the amount of cell surface Kd was determined by mAb staining and
analyzed by flow cytometry.given a vector that is not itself closely related immuno-
logically to a potential pathogen (such as avipox vec-
TCD81 Functional Assaystors), the mTCD81 are at best useless and at worst, a For ICS, following lysis of erythrocytes, splenocytes were resus-
potential source of autoimmunity. The advantage of vac- pended at 107/ml in I-10, and 200 ml were added per well to round-
cines based on the immunization of modified forms of bottom 96-well plates. Peptides were added to a concentration
of 0.5 mM. In the case of Cys containing peptides, media werethe target pathogen is that they focus immune re-
supplemented with 200 mM of TCEP to prevent sulfhydryl modifica-sponses on relevant antigens.
tion. For established TCD81 lines, peptide-pulsed P815 cells were
used. After 2 hr incubation at 378C, BFA was added and cells were
Experimental Procedures incubated for a further 3 hr to accumulate IFNg in the ER of activated
cells. Cells were then incubated with a fluorescein-conjugated anti-
Monoclonal Antibodies and Other Reagents CD8a mAb on ice for 30 min, washed, fixed with 1% paraformalde-
All mAbs were FITC labeled except PE-labeled anti-IFNg, and all hyde in PBS at 208C for 20 min, and then incubated with phycoer-
were purchased from PharMingen. The anti-Kd mAb SF1-1.1 was ythrin-conjugated anti-IFNg mAb diluted in PBS containing 0.1%
used for all peptide binding and decay assays. All mAbs were used saponin. Stained cells were analyzed by flow cytometry gating on
at 1:100 dilution in PBS supplemented with 0.1% BSA. Anti-CD4 the CD81 cells. 51Cr-release assays were performed as described
mAb culture supernatant from hybridoma GK1.5 and unlabeled anti- (Chen et al., 1999). Data are expressed as % specific lysis 5 (TCD81
B220 antibody (PharMingen) were used to coat M450 Dynal beads induced release - spontaneous release)/(release by detergent -
(Dynal, Holland) for depleting CD41 cells and B2201 activated LAK spontaneous release) 3 100.
and NK cells.
HPLC Fractionation and Quantitation of Viral Peptides
TCD81 Purification This method has been described by AntoÂ n et al. (1997).
PR8-primed splenocytes were stimulated by PR8-infected P815
cells for 7 days. The stimulated T cells (more than 95% are CD81) Acknowledgments
were positively selected for Vb8.1/8.2 TCR expression using FITC-
labeled Vb mAb, and the resulting Vb8.1/8.2 negative population Bethany Buschling provided outstanding technical assistance. W. C.
was then further depleted of Vb6, or Vb6, Vb8.3, and Vb10 express- was supported by a C. J. Martin Fellowship (967036) from the Austra-
ing cells. anti-FITC antibody-conjugated microbeads and positive lia National Health and Medical Research Council.
selection columns were used (Miltenyi, Germany) for all the enrich-
ment and depletion steps. The purity of selected populations was Received September 7, 1999; revised December 8, 1999.
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